Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Weekly shot could replace daily needles for kids with growth disorders

NCT ID NCT05330325

Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a new growth hormone medicine (somapacitan) given once a week works as well as the standard daily growth hormone (Norditropin) for children who are very short due to being born small, or having Turner syndrome, Noonan syndrome, or unknown causes. About 412 children will take part for up to 5.5 years. The goal is to see if the weekly shot improves growth speed and height, with fewer injections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

412 people

The number who actually took part.

Started

Aug 2022

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

2 to 10 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. Informed consent of parent or legally acceptable representative of participant and child assent, as age appropriate must be obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study. 2. No prior exposure to growth promoting therapy, including but not limited to growth hormone, IGF-I and ghrelin analogues. Applicable to children with SGA: 3. Born small for gestational age (birth length below -2 SDS OR birth weight below -2 SDS OR both) (according to national standards). 4. Prepubertal children: 1. Boys: * Age above or equal to 2 years and 26 weeks and below 11.0 years at screening. * Testis volume below 4 mL 2. Girls: * Age above or equal to 2 years and 26 weeks and below 10.0 years at screening. * Tanner stage 1 for breast development: No palpable glandular breast tissue) 5. Impaired height defined as at least 2.5 standard deviations below the mean height for chronological age and sex at screening according to the standards of Centers for Disease Control and Prevention. 6. Impaired height velocity defined as annualized height velocity below the 50th percentile for chronological age and sex according to the standards of Prader calculated over a time span of minimum 6 months and maximum 18 months prior to screening. 7. Body Mass Index below the 95th percentile according to Centers for Disease Control and Prevention, Body Mass Index-for-age growth charts. Applicable to girls with TS: 8. Confirmed diagnosis of TS by 30-cell (or more) lymphocyte chromosomal analysis.\* 9. Prepubertal girls: * Age above or equal to 2 years and 26 weeks and below 10.0 years at screening. * Tanner stage 1 for breast development: No palpable glandular breast tissue) 10. Impaired height defined as at least 2.0 standard deviations below the mean height for chronological age and sex at screening according to the standards of Centers for Disease Control and Prevention. 11. Historical height measured 6-18 months prior to screening. 12. Thyroid hormone replacement therapy should be adequate and stable for at least 90 days prior to randomization, if applicable. Applicable to children with NS: 13. Clinical diagnosis of NS according to van der Burgt score list 14. Prepubertal children: 1. Boys: * Age above or equal to 2 years and 26 weeks and below 11.0 years at screening. * Testis volume below 4 mL 2. Girls: * Age above or equal to 2 years and 26 weeks and below 10.0 years at screening. * Tanner stage 1 for breast development: No palpable glandular breast tissue) 15. Impaired height defined as at least 2.0 standard deviations below the mean height for chronological age and sex at screening according to the standards of Centers for Disease Control and Prevention. 16. Historical height measured 6-18 months prior to screening. 17. Thyroid hormone replacement therapy should be adequate and stable for at least 90 days prior to randomization, if applicable. Applicable to children with ISS: 18. Prepubertal children: 1. Boys: * Age above or equal to 2 years and 26 weeks and below 11.0 years at screening. * Testis volume below 4 mL 2. Girls: * Age above or equal to 2 years and 26 weeks and below 10.0 years at screening. * Tanner stage 1 for breast development: No palpable glandular breast tissue) 19. Bone age: 1. Boys: * Bone age below or equal to 12 years. * Bone age not delayed or advanced more than 2 years compared to chronological age. 2. Girls: * Bone age below or equal to 11 years. * Bone age not delayed or advanced more than 2 years compared to chronological age. 20. Impaired height defined as at least 2.5 standard deviations below the mean height for chronological age and sex at screening according to the standards of Centers for Disease Control and Prevention. 21. Historical height measured 6-18 months prior to screening. 22. One normal GH secretion (GH peak above 7 ng/mL) during GH stimulation test performed within 18 months prior to screening or if such a test is not available for children with ISS, a test should be performed as part of the screening assessments and the result must be available prior to randomization. * If a 30-cell count is not available for patients with TS, a test should be done, and results must be available prior to randomization. Exclusion criteria: 1. Known or suspected hypersensitivity to study intervention(s) or related products. 2. Previous randomization into same sub-study in this study. 3. Receipt of any investigational medicinal product within 3 months before screening or participation in another clinical study at the time of randomization. 4. Children with suspected or confirmed growth hormone deficiency according to local practice. 5. laboratory of 1. fasting plasma glucose above or equal to 126 mg/dL (7.0 mmol/L) or 2. HbA1c above or equal to 6.5%. 6. Current inflammatory diseases requiring systemic corticosteroid treatment for longer than 2 consecutive weeks within the last 3 months prior to screening. 7. Children requiring inhaled glucocorticoid therapy at a dose greater than 400 µg/day of inhaled budesonide or equivalent (i.e., 250 µg/day for fluticasone propionate) for longer than 4 consecutive weeks within the last 12 months prior to screening. 8. Concomitant administration of other treatments that may have an effect on growth, e.g., but not limited to methylphenidate for treatment of attention deficit hyperactivity disorder (ADHD). 9. Diagnosis of attention deficit hyperactivity disorder (ADHD). 10. History or known presence of any malignancy, intracranial tumour, or intracranial cyst. 11. History or known presence of active Hepatitis B or Hepatitis C (exceptions to this exclusion criterion is the presence of antibodies due to vaccination against Hepatitis B). 12. Any disorder, which in the investigator's opinion, might jeopardize participant's safety or compliance with the protocol. 13. The participant or the parent/legally acceptable representative is likely to be non-compliant in respect to study conduct, as judged by the investigator. 14. Current treatment with sex hormones or aromatase inhibitors. 15. Any known or suspected clinically significant abnormality likely to affect growth or the ability to evaluate growth with standing height measurements, such as, but not limited to: 1. Known family history of skeletal dysplasia. 2. Significant spinal abnormalities including but not limited to scoliosis, kyphosis and spina bifida variants. 3. Any other disorder/condition that can cause short stature such as, but not limited to, psychosocial deprivation, nutritional disorders, chronic systemic illness and chronic renal disease. Applicable to children with SGA: 1. TS (including mosaicism). 2. NS. 3. Hormonal deficiencies. 4. Children who are small due to malnutrition defined as -2 standard deviations according to standards. 0¬-5 years: weight for height on World Health Organization Multicentre Growth Reference Study 2006. Above 5 years: World Health Organization 2007 Body Mass Index. 5. Known chromosomal aneuploidy or significant gene mutations causing medical 'syndromes' with short stature, including but not limited to Laron syndrome, Prader-Willi syndrome, Russell-Silver Syndrome, skeletal dysplasias, abnormal SHOX gene analysis or absence of GH receptors. Applicable to children with TS: 1. NS. 2. Mosaicism below 10%. 3. TS with Y-chromosome mosaicism where gonadectomy has not been performed. 4. NYHA class II or above or requiring medication for any heart condition. 5. Coeliac disease where participant is not stable on gluten free diet for the previous 12 months prior to screening. Applicable to children with NS: 1. TS (including mosaicism). 2. Noonan-related disorders: Noonan syndrome with multiple lentigines (formerly called 'LEOPARD' syndrome), Noonan syndrome with loose anagen hair, cardiofaciocutaneous syndrome (CFC), Costello syndrome, neurofibromatosis type 1 (NF1) and Legius syndrome. Molecular genetic panel testing results must be available prior to randomisation to exclude these. 3. Coeliac disease where participant is not stable on gluten free diet for the previous 12 months prior to screening. Applicable to children with ISS: 1. TS (including mosaicism). 2. NS. 3. Hormonal deficiencies. 4. Born small for gestational age (defined as birth length below -2 SDS OR birth weight below -2 SDS OR both) (according to national standards). 5. Known chromosomal aneuploidy or significant gene mutations causing medical 'syndromes' with short stature, including but not limited to Laron syndrome, Prader-Willi syndrome, Russell-Silver Syndrome, skeletal dysplasias, abnormal SHOX gene analysis or absence of GH receptors.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Idiopathic short stature are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fetal growth restriction isolated short stature Noonan syndrome Turner syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sga, Turner syndrome, Noonan syndrome, iss

Contacts and locations

Locations

  • "AHEPA" University General Hospital of Thessaloniki

    Thessaloniki, 54636, Greece

  • "AHEPA" University General Hospital of Thessaloniki

    Thessaloniki, GR-54636, Greece

  • 'Ippokrateio' General Hospital of Thessaloniki

    Thessaloniki, 546-42, Greece

  • Addenbrooke's Hospital_Cambridge

    Cambridge, CB2 0QQ, United Kingdom

  • Akron Children's Hospital

    Akron, Ohio, 44308, United States

  • Alder Hey Children's Hospital

    Liverpool, L12 2AP, United Kingdom

  • All India Institute of Medical Sciences

    New Dehli, New Delhi, 110029, India

  • Amrita Institute Of Medical Sciences & Research Centre

    Kochi, Kerala, 682041, India

  • Ap-Hp-Hopital Necker

    Paris, 75015, France

  • Ap-Hp-Hopital de Bicetre

    Le Kremlin-Bicêtre, 94270, France

  • Asan Medical Center

    Seoul, 05505, South Korea

  • Assistance Publique Hopitaux de Marseille-Hopital de La Timone-2

    Marseille, 13005, France

  • Atlanta Diabetes Associates

    Atlanta, Georgia, 30318, United States

  • Bambin Gesù

    Roma, 00165, Italy

  • Beijing Children's Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100045, China

  • CCHMC_Cinc

    Cincinnati, Ohio, 45229, United States

  • CHI Crumlin Dept of Endocrinology

    Dublin, D12 N512, Ireland

  • CHI Tallaght University Hospital

    Dublin, D24NR0A, Ireland

  • CHI at Temple Street

    Dublin, D01 XD99, Ireland

  • CHU Pellegrin

    Bordeaux, 33076, France

  • CHU de Toulouse

    Toulouse, 31059, France

  • CPQuali Pesquisa Clínica Ltda

    São Paulo, São Paulo, 01228-000, Brazil

  • Centre Hospitalier Régional Universitaire d' Angers

    Angers, 49033, France

  • Centre Hospitalier Universitaire D'Angers-2

    Angers, 49100, France

  • Centre Hospitalier Universitaire de Bordeaux-Hopital Pellegrin

    Bordeaux, 33000, France

  • Centro Hospitalar Lisboa Norte

    Lisbon, 1649-035, Portugal

  • Centro de Diabetes Curitiba

    Curitiba, Paraná, 80810-040, Brazil

  • Centro de Pesquisa Clínica do Hospital das Clínicas da Faculdade de Medicina da USP

    São Paulo, São Paulo, 05403-000, Brazil

  • Chengdu Women's and Children's Central Hospital

    Chengdu, Sichuan, 610000, China

  • Children's Clinical University Hospital

    Riga, 1004, Latvia

  • Children's Hosp-East Ontario

    Ottawa, Ontario, K1H 8L1, Canada

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Children's Hospital Los Angeles - Endocrinology

    Los Angeles, California, 90027, United States

  • Children's Minnesota

    Saint Paul, Minnesota, 55102, United States

  • Childrens National Medical Ctr

    Washington D.C., District of Columbia, 20010-2978, United States

  • Childrens' Hospital of Athens "Agia Sofia"

    Goudi/Athens, 115-27, Greece

  • Chungnam National University Sejong Hospital

    Sejong-si, 30099, South Korea

  • Cliniques Universitaires Saint-Luc - Serv. Pédiatrie

    Brussels, 1200, Belgium

  • Complejo Hospitalario Universitario de Santiago

    Santiago de Compostela, A Coruña, 15706, Spain

  • Consano Clinical Research, LLC

    Shavano Park, Texas, 78231, United States

  • Consultorio de Endocrinología y Pediatría

    Puebla City, 72190, Mexico

  • Cook Children's Medical Center

    Fort Worth, Texas, 76104, United States

  • Cork University Hospital

    Cork, Ireland

  • Department of Peadiatrics CHBAH

    Johannesburg, Gauteng, 1864, South Africa

  • Dr JC van Dyk's Rooms

    Pretoria, Gauteng, 0181, South Africa

  • Dr K Pillay's site

    Westville, KwaZulu-Natal, 3600, South Africa

  • Dr Y Ganie's site

    Mayville, KwaZulu-Natal, 4058, South Africa

  • Endokrinologikum Frankfurt

    Frankfurt am Main, 60596, Germany

  • Erasmus MC

    Rotterdam, 3015 GD, Netherlands

  • Evelina Children's Hospital - St Thomas'

    London, SE1 7EH, United Kingdom

  • Evelina London Children's Hospital

    London, SE1 7EH, United Kingdom

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Rome, 00168, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCS

    Rome, 00168, Italy

  • Fujita Health University Hospital, Pediatrics

    Toyoake, Aichi, 470-1192, Japan

  • Fukuoka Children's Hospital

    Fukuoka-shi, Fukuoka, 813-0017, Japan

  • Fukuoka Children's Hospital_Endocrinology and Metabolism

    Fukuoka-shi, Fukuoka, 813-0017, Japan

  • General University of Patra - Paediatric Department

    Pátrai, 26504, Greece

  • Goryeb Children's Hospital

    Morristown, New Jersey, 07962, United States

  • Górnośląskie Centrum Zdrowia Dziecka Szpital Kliniczny Nr 6

    Katowice, 40-752, Poland

  • H.Madrid Montepríncipe

    Boadilla del Monte, Madrid, 28660, Spain

  • HUS Pediatric Unit

    Helsinki, 00290, Finland

  • Henan Children's Hospital Zhengzhou Children's Hospital-Endocrine Genetics and Metabolism

    Zhengzhou, Henan, 450018, China

  • Hokkaido University Hospital, Pediatrics

    Sapporo, Hokkaido, 060-8648, Japan

  • Hokkaido University Hospital_Pediatrics

    Sapporo, Hokkaido, 060-8648, Japan

  • Hopital Des Enfants

    Toulouse, 31059, France

  • Hopital de Bicetre_Le Kremlin-Bicetre

    Le Kremlin-Bicêtre, 94275, France

  • Hopital de La Timone

    Marseille Cédex 05, 13385, France

  • Hospital Al-Sultan Abdullah UiTM

    Bandar Puncak Alam, Selangor, 42300, Malaysia

  • Hospital Madrid Montepríncipe

    Boadilla del Monte, Madrid, 28660, Spain

  • Hospital Sant Joan de Déu

    Esplugues de Llobregat, 08950, Spain

  • Hospital Universiti Sains Malaysia_Kota Bharu, Kelantan

    Kota Bharu, Kelantan, 16150, Malaysia

  • Hospital of Lithuanian University of Health Sciences Kauno klinikos

    Kaunas, 50161, Lithuania

  • Hull Royal Infirmary

    Hull, HU3 2JZ, United Kingdom

  • Hunan Children's Hospital-Child Health Center

    Changsha, Hunan, 410007, China

  • Hyogo Prefectual Kobe Children's Hospital Dept. Metab & endo

    Kobe-shi, Hyogo, 650-0047, Japan

  • Hyogo Prefectual Kobe Children's Hospital_Metab & endo

    Kobe-shi, Hyogo, 650-0047, Japan

  • Hôpital Necker

    Paris, 75015, France

  • IRCCS Meyer Firenze

    Florence, 50139, Italy

  • Institute for Health Care of Children and Adolescents

    Novi Sad, 21000, Serbia

  • Institute for Mother and Child Health Care of Serbia

    Belgrade, 11070, Serbia

  • Institute of Science Tokyo Hospital

    Tokyo, 113-8519, Japan

  • Institute of Science Tokyo Hospital_Pediatrics

    Tokyo, 113-8519, Japan

  • Ippokrateio Gen Hosp of Thessaloniki, 1st Pediatric Clinic

    Thessaloniki, 54642, Greece

  • Ippokrateio Gen Hosp of Thessaloniki, 1st Pediatric Clinic

    Thessaloniki, GR 54642, Greece

  • Jehangir Clinical Development Centre

    Pune, Maharashtra, 411001, India

  • KBC "Sestre Milosrdnice"

    Zagreb, 10 000, Croatia

  • KBC Zagreb, Zavod za dječju endokrinologiju i dijabetes

    Zagreb, 10000, Croatia

  • Keio University Hospital_Pediatrics

    Tokyo, 160-8582, Japan

  • Kepler Universitätsklinikum GmbH - Med Campus IV (vorm.LFKK)

    Linz, Upper Austria, 4020, Austria

  • King Chulalongkorn Memorial hospital-Ped-Endocrinology

    Bangkok, 10330, Thailand

  • King Chulalongkorn Memorial hospital_Ped-Endocrinology

    Bangkok, 10330, Thailand

  • King Faisal Specialist Hospital & Research Centre, Riyadh

    Riyadh, 12713, Saudi Arabia

  • Kliniczny Szpital Wojewodzki nr 2 im. Sw. Jadwigi Krolowej w Rzeszowie

    Rzeszów, Podkarpackie Voivodeship, 35-301, Poland

  • Klinik für Allgemeine Pädiatrie und Neonatologie

    Homburg, 66421, Germany

  • Klinika Endokrynologii i Chorób Metabolicznych

    Lodz, 93-338, Poland

  • Klinika Pediatrii SUM, SPSK nr 1 im. prof.S.Szyszko w Zabrzu_LOC#1

    Zabrze, 41-800, Poland

  • Krankenhaus der Stadt Dornbirn

    Dornbirn, 6850, Austria

  • LKH St. Poelten, Kinder-und Jugendheilkunde

    Sankt Pölten, 3100, Austria

  • Liuzhou Maternity and Child Healthcare Hospital-Child Healthcare

    Liuzhou, Guangxi, 545001, China

  • Maharaj Nakorn Chiang Mai Hospital_Pediatric Endocrinology

    Chiang Mai, 50200, Thailand

  • Marshfield Clinic

    Marshfield, Wisconsin, 54449, United States

  • Med. Kinder- und Poliklinik

    Bern, 3010, Switzerland

  • MultiCare Inst for Res & Innov

    Tacoma, Washington, 98405, United States

  • NYU Langone Hospital-LI

    Garden City, New York, 11530, United States

  • NYU Langone Hospital-LI

    Mineola, New York, 11501, United States

  • Nara Prefecture General Medical Center

    Nara-shi, Nara, 630-8581, Japan

  • Nara Prefecture General Medical Center_Nephrology

    Nara-shi, Nara, 630-8581, Japan

  • National Center for Child Health and Development_Endo and Metabo

    Tokyo, 157 8535, Japan

  • National Guard Hospital

    Riyadh, 14812, Saudi Arabia

  • Nemours Chld Clnc Jacksonville

    Jacksonville, Florida, 32207, United States

  • Nemours/AI duPont Hosp-Chld

    Wilmington, Delaware, 19803, United States

  • Niigata University Medical & Dental Hospital_Pediatrics

    Niigata-shi, Niigata, 951 8520, Japan

  • Okayama Medical Center_Cardiology

    Okayama-shi, Okayama, 701-1192, Japan

  • Osaka City General Hospital, Pediatric Endocrinology and Me

    Osaka, 534-0021, Japan

  • Osaka Women's and Children's Hospital

    Osaka, 594-1101, Japan

  • Ospedale Pediatrico Bambino Gesu

    Roma, 00165, Italy

  • Ospedale Pediatrico Gaslini

    Genova, 16147, Italy

  • Ospedale San Raffaele S.r.l. - Unità Clinica Pediatria e neonatologia

    Milan, Lombardy, 20132, Italy

  • Ospedale San Raffaele UO di Pediatria e UO di Neonatologia

    Milan, 20132, Italy

  • P & A Kyriakou Childrens' Hospital - Department of Endocrinology Growth and Development

    Goudi/Athens, 115-27, Greece

  • PMK - Paediatrics Endocrinology Centre

    Bangkok, 10400, Thailand

  • PeK - Dept. of Paediatric Endocrinology, Diabetes and Metabolism

    Ljubljana, 1525, Slovenia

  • Ped Endo Assoc PC-G.V

    Greenwood Village, Colorado, 80111-2803, United States

  • Phramongkutklao Hospital_Ped-Endo_Pediatrics

    Bangkok, 10400, Thailand

  • Pusan National University Yangsan Hospital

    Yangsan, Gyeongsangnam-do, 50612, South Korea

  • Rady Childrens Hosp San Diego

    San Diego, California, 92123, United States

  • Ramathibodi Hospital - Ped-Endo and Metabolism

    Ratchathewi, Bangkok, 10400, Thailand

  • Ramathibodi Hospital - Ped-Endo and Metabolism

    Bangkok, Ratchathewi, 10400, Thailand

  • Rambam MC - Department of Pediatrics A

    Haifa, 31096, Israel

  • Riley Hosp for Child-Indiana U

    Indianapolis, Indiana, 46202, United States

  • Rocky Mt Clin Res, LLC

    Idaho Falls, Idaho, 83404-7596, United States

  • Rocky Mt Ped and Endo

    Centennial, Colorado, 80112, United States

  • Royal Manchester Children's Hospital

    Manchester, M13 9WL, United Kingdom

  • SHATPD - Prof. Ivan Mitev EAD

    Sofia, 1606, Bulgaria

  • SPSK nr 1 im Prof. T Sokolowskiego

    Szczecin, 71-252, Poland

  • SPSK nr 1 im. prof.S.Szyszko w Zabrzu

    Zabrze, 41-800, Poland

  • Saitama Children's Medical Center, Endocrinorogy&Metabolism

    Saitama-shi, Saitama, 330-8777, Japan

  • Salzkammergut-Klinikum Vöcklabruck

    Vöcklabruck, 4840, Austria

  • Santa Casa Sao Paulo

    São Paulo, São Paulo, 01223-001, Brazil

  • Sanya Central Hospital (Hainan Third People's Hospital)-Pediatric

    Sanya, Hainan, 572032, China

  • Schneider MC - Endrocrinology and Diabetes

    Petah Tikva, 49202, Israel

  • Severance Hospital, Yonsei University Health System

    Seoul, 03722, South Korea

  • Shamir MC - Pediatric and Adolescents Endocrinology unit

    Ẕerifin, 7033001, Israel

  • Shandong Provincial Hospital-Pediatric

    Jinan, Shandong, 250098, China

  • Shanghai Children's Hospital -Endocrine Genetics and Metabolism

    Shanghai, Shanghai Municipality, 200062, China

  • Shanghai Children's Medical Center-Endocrine Genetics and Metabolism

    Shanghai, Shanghai Municipality, 200127, China

  • Sheba MC - Pediatric endocrinology and adolescent diabetes clinics

    Tel Litwinsky, 52621, Israel

  • Shizuoka Children's Hospital, Department of Diabetes and metabolism

    Shizuoka-shi, Shizuoka, 420-8660, Japan

  • Siriraj Hospital_Dept of Paediatrics

    Bangkok, 10700, Thailand

  • Soroka MC - Pediatric Endocrinology

    Beersheba, 84101, Israel

  • Srinagarind Hospital

    Khon Kaen, 40002, Thailand

  • St George's Hospital

    Tooting, SW17 0RE, United Kingdom

  • St Georges Hospital

    Tooting, SW17 0RE, United Kingdom

  • St. Luke's Children's Endo

    Boise, Idaho, 83712, United States

  • Sutter Valley Med Fdt Ped Endo

    Sacramento, California, 95821, United States

  • The Children's Mercy Hospital

    Kansas City, Missouri, 64108, United States

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, 510080, China

  • The First Bethune Hospital of Jilin University-Pediatric

    Changchun, Jilin, 130021, China

  • Tongji Hospital, Tongji Medical College of HUST-Pediatric

    Wuhan, Hubei, 430030, China

  • U.G.H. "Attikon", Pediatric Endocrinology Outpatient Clinic

    Athens, 12462, Greece

  • UBMD Peds-Div of Endo/Diabetes

    Buffalo, New York, 14203, United States

  • UCK, Klinika Pediatrii, Diabetologii i Endokrynologii,

    Gdansk, 80-952, Poland

  • ULS De Gaia/Espinho_H.Santos Silva_Pediatria

    Vila Nova de Gaia, 4400-129, Portugal

  • ULS De Santo António, E.P.E. - Hospital de Santo António

    Porto, 4050-651, Portugal

  • ULS De São José, E.P.E.- Hospital D. Estefânia

    Lisbon, 1169-045, Portugal

  • UMHAT - Dr. Georgi Stranski EAD

    Pleven, 5800, Bulgaria

  • UMHAT Sveta Marina EAD, First Pediatric Clinic

    Varna, 9010, Bulgaria

  • UMHAT Sveti Georgi EAD, Plovdiv, Clinic of Pediatrics

    Plovdiv, 4002, Bulgaria

  • UMass Medical School

    Worcester, Massachusetts, 01655, United States

  • UPMC Child Hosp-Pittsburgh

    Pittsburgh, Pennsylvania, 15224, United States

  • UT Southwestern Med Cntr

    Dallas, Texas, 75235, United States

  • UZ Brussel

    Brussels, 1090, Belgium

  • UZ Leuven - Kindergeneeskunde

    Leuven, 3000, Belgium

  • UZA - UZ Antwerpen - Kinderziekenhuis

    Edegem, 2650, Belgium

  • Unidade De Santa Maria E.P.E. - Hospital de Santa Maria

    Lisbon, 1649-035, Portugal

  • Univ Oklahoma Sci Ctr OK City

    Oklahoma City, Oklahoma, 73104, United States

  • Univ of AL at Birmingham_BRM

    Birmingham, Alabama, 35233, United States

  • Univ of Minnesota M.C.H.

    Minneapolis, Minnesota, 55454, United States

  • Univ of Mississippi Med Ctr

    Jackson, Mississippi, 39216, United States

  • Univ.HP, Kyoto Pref Univ of Medicine, Dept. of Pediatrics

    Kyoto, 602-8566, Japan

  • University Children's Hospital

    Ljubljana, 1525, Slovenia

  • University Children's Hospital Tirsova

    Belgrade, 11000, Serbia

  • University Clinical Centre Kragujevac

    Kragujevac, 34000, Serbia

  • University Clinical Centre Nis

    Niš, RS, 18 000, Serbia

  • University Clinical Centre Nis

    Niš, 18 000, Serbia

  • University Malaya Medical Centre

    Kuala Lumpur, Kuala Lumpur, 59100, Malaysia

  • University Malaya Medical Centre

    Lembah Pantai, Kuala Lumpur, 59100, Malaysia

  • University OF Iowa

    Iowa City, Iowa, 52242, United States

  • University Of Virginia Hospital

    Charlottesville, Virginia, 22903, United States

  • University Technology MARA (UiTM) - Puncak Alam

    Bandar Puncak Alam Selangor Darul Ehsan, 42300, Malaysia

  • Università degli Studi della Campania "L. Vanvitelli"

    Naples, 80138, Italy

  • Universität des Saarlandes - Pädiatrie und Neonatologie

    Homburg, 66424, Germany

  • Universitätsklinikum Bonn - Kinderklinik

    Bonn, 53127, Germany

  • Universitätsklinikum Erlangen - Kinder- und Jugendklinik

    Erlangen, 91054, Germany

  • Uniwer. Szpital Dzieciecy Klinika Endokry. Dzieci i Mlodzie

    Cracow, 30-663, Poland

  • Uniwersytecki Szptal Dziecięcy w Krakowie

    Cracow, 30-663, Poland

  • WakeMed Childn Endo-Dbt_Raleig

    Raleigh, North Carolina, 27610, United States

  • Wuhan Children Hospital

    Wuhan, Hubei, 430019, China

  • Wuhan Children Hospital-Endocrine Genetics and Metabolism

    Wuhan, Hubei, 430019, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.